Form 4 for REGN Regeneron Pharmaceuticals
Accepted 2023-03-29 00:00:00 ET · period of report 2023-03-27 · accession 0001968202-23-000004 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2023-03-29 | 2023-03-27+ | REGN | Landry Robert E | EVP Fin CFO | S - Sale+OE | $823.20 | -1,190 | 32.9K | -3% | -$979.6K |
| DM | 2023-03-29 | 2023-03-27 | REGN | Landry Robert E | EVP Fin CFO | M - OptEx | $379.60 | +3,800 | 35.3K | +12% | +$1.44M |
| DM | 2023-03-29 | 2023-03-27 | REGN | Landry Robert E | EVP Fin CFO | F - Tax | $825.17 | -2,793 | 33.1K | -8% | -$2.30M |
| DM | 2023-03-29 | 2023-03-27 | REGN | Landry Robert E | EVP Fin CFO | M - OptEx | $0.00 | -3,800 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-03-28 | S | D | 142 | $821.40 | 32,662 | D | — | — | (F7) Represents volume-weighted average price of sales of 142 shares of Company stock on March 28, 2023 at prices ranging from $821.04 to $821.73. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on March 28, 2023 at each separate price. |
| 2 | Common | Common Stock | 2023-03-28 | S | D | 128 | $822.67 | 32,534 | D | — | — | (F8) Represents volume-weighted average price of sales of 128 shares of Company stock on March 28, 2023 at prices ranging from $822.21 to $822.87. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on March 28, 2023 at each separate price. |
| 3 | Common | Common Stock | 2023-03-28 | S | D | 115 | $820.85 | 32,804 | D | — | — | (F6) Represents volume-weighted average price of sales of 115 shares of Company stock on March 28, 2023 at prices ranging from $820.67 to $820.91. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on March 28, 2023 at each separate price. |
| 4 | Common | Common Stock | 2023-03-28 | S | D | 181 | $823.60 | 32,353 | D | — | — | (F9) Represents volume-weighted average price of sales of 181 shares of Company stock on March 28, 2023 at prices ranging from $823.02 to $823.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on March 28, 2023 at each separate price. |
| 5 | Common | Common Stock | 2023-03-28 | S | D | 157 | $824.54 | 32,196 | D | — | — | (F10) Represents volume-weighted average price of sales of 157 shares of Company stock on March 28, 2023 at prices ranging from $824.00 to $824.74. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on March 28, 2023 at each separate price. |
| 6 | Common | Common Stock | 2023-03-28 | S | D | 243 | $825.37 | 31,953 | D | — | — | (F11) Represents volume-weighted average price of sales of 243 shares of Company stock on March 28, 2023 at prices ranging from $825.02 to $825.82. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on March 28, 2023 at each separate price. |
| 7 | Common | Common Stock | 2023-03-28 | S | D | 31 | $826.36 | 31,922 | D | — | — | |
| 8 | Common | Common Stock | 2023-03-27 | M | A | 800 | $381.92 | 32,905 | D | — | — | |
| 9 | Common | Common Stock | 2023-03-27 | F | D | 589 | $825.17 | 32,316 | D | — | — | |
| 10 | Common | Common Stock | 2023-03-27 | M | A | 3,000 | $378.98 | 35,316 | D | — | — | |
| 11 | Common | Common Stock | 2023-03-27 | F | D | 2,204 | $825.17 | 33,112 | D | — | — | |
| 12 | Common | Common Stock | 2023-03-27 | S | D | 39 | $819.47 | 33,073 | D | — | — | (F2) Represents volume-weighted average price of sales of 39 shares of Company stock on March 27, 2023 at prices ranging from $819.34 to $819.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on March 27, 2023 at each separate price. |
| 13 | Common | Common Stock | 2023-03-27 | S | D | 50 | $820.46 | 33,023 | D | — | — | (F3) Represents volume-weighted average price of sales of 50 shares of Company stock on March 27, 2023 at prices ranging from $820.00 to $820.95. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on March 27, 2023 at each separate price. |
| 14 | Common | Common Stock | 2023-03-27 | S | D | 48 | $821.39 | 32,975 | D | — | — | (F4) Represents volume-weighted average price of sales of 48 shares of Company stock on March 27, 2023 at prices ranging from $821.02 to $821.77. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on March 27, 2023 at each separate price. |
| 15 | Common | Common Stock | 2023-03-27 | S | D | 18 | $822.57 | 32,957 | D | — | — | (F5) Represents volume-weighted average price of sales of 18 shares of Company stock on March 27, 2023 at prices ranging from $822.46 to $822.71. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on March 27, 2023 at each separate price. |
| 16 | Common | Common Stock | 2023-03-27 | S | D | 4 | $824.30 | 32,953 | D | — | — | |
| 17 | Common | Common Stock | 2023-03-27 | S | D | 13 | $825.59 | 32,940 | D | — | — | |
| 18 | Common | Common Stock | 2023-03-27 | S | D | 4 | $829.16 | 32,936 | D | — | — | |
| 19 | Common | Common Stock | 2023-03-27 | S | D | 7 | $830.01 | 32,929 | D | — | — | |
| 20 | Common | Common Stock | 2023-03-28 | S | D | 10 | $818.81 | 32,919 | D | — | — | |
| 21 | Derivative | Non-Qualified Stock Option (right to buy) | 2023-03-27 | M | D | 3,000 | $0.00 | 20,337 | D | $378.98 · — to 2027-12-12 | 3,000 Common Stock | (F12) The stock option award vests in four equal annual installments, commencing one year after the date of grant. |
| 22 | Derivative | Non-Qualified Stock Option (right to buy) | 2023-03-27 | M | D | 800 | $0.00 | 0 | D | $381.92 · — to 2026-12-16 | 800 Common Stock | (F12) The stock option award vests in four equal annual installments, commencing one year after the date of grant. |